Utah Medical Products traded at $63.13 this Thursday March 26th, decreasing $0.58 or 0.91 percent since the previous trading session. Looking back, over the last four weeks, Utah Medical Products lost 5.22 percent. Over the last 12 months, its price rose by 11.30 percent. Looking ahead, we forecast Utah Medical Products to be priced at 61.80 by the end of this quarter and at 56.40 in one year, according to Trading Economics global macro models projections and analysts expectations.
Utah Medical Products, Inc. (UTMD) manufactures and markets a range of specialty medical devices. Its product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME and OptiMicro electrosurgical devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. Its medical devices are sold directly to clinical end-user facilities or a designated stocking distributor for a medical facility. In addition, some of its devices are sold through distributors and national hospital distribution companies.